REGENERON PHARMACEUTICALS $254.87

down -7.55


23/5/2013 04:23 PM  |  NASDAQ : REGN  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
12 Mo. Price Change : 102% - REGN has outperformed the S&P 500 by 77%

Get Trend Analysis Icon Get Trend Analysis

Partner Headlines

  1. Regeneron, Alexion Top; Fall

    Investors Business Daily

  2. Earnings Scheduled For February 14, 2013

    Benzinga

  3. Celgene, Regeneron Get Some Favorable News

    Investors Business Daily

  4. Regeneron, Alexion Big-Cap Biotechs Sales Seen Rising

    Investors Business Daily

  5. Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

    Benzinga

  6. Celgene, Regeneron Get Some Favorable News

    Investors Business Daily

  7. Stocks Narrow To Thin Red Line; Generac Backslides

    Investors Business Daily

  8. UPDATE: Regeneron Pharm Announces Receipt of HSR Notice Sanofi to ...

    Benzinga

  9. Allergan Reports Mixed Q4, But Bullish Margin Outlook

    Investors Business Daily

  10. Netflix Leads Top 5 Techs Smashing Profit Forecasts

    Investors Business Daily

  11. Top Mutual Funds Still Nibbling At Ocwen Financial

    Investors Business Daily

  12. Jefferies Reiterates Buy Rating, $34 PT on Partnership with ...

    Benzinga

  13. Regeneron, Other Biomed Stocks Rebound On New Drugs

    Investors Business Daily

  14. Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

    Benzinga

  15. Regeneron Pharmaceuticals, Inc. (REGN) SVP Finance and Admin CFO ...

    GuruFocus

  16. Alkermes Trades Tightly, Holds In Buying Range

    Investors Business Daily

  17. Regeneron Forms New Base, But It's Late Stage

    Investors Business Daily

  18. Regeneron Forms New Base, But It's Late Stage

    Investors Business Daily

  19. 5 Key Stock Moves From JPMorgan Health Care Confab

    Investors Business Daily

  20. Stocks Climb Modestly; CommVault Reverses Higher

    Investors Business Daily

  21. Stocks Hold Modest Gains; MI Homes Hits Multiyear High

    Investors Business Daily

  22. Eylea Sales Hurt Regeneron

    Investors Business Daily

  23. Stock Indexes Dip As Earnings Season Set To Begin

    Investors Business Daily

  24. Stocks Push Off Day's Lows; Regeneron Cuts More Losses

    Investors Business Daily

  25. Regeneron Shares Fall After Sales Of Eye Drug Posted

    Investors Business Daily

  26. Stocks Give Up More Ground; 3D Systems Reverses Lower

    Investors Business Daily

  27. Stocks Open Down In Weak Trade; Signet Jewelers Glimmers

    Investors Business Daily

  28. Benzinga's M&A Chatter for Friday January 4, 2013

    Benzinga

  29. Top 100 Stocks Of 2012 Include Builders, Biotech, 3D

    Investors Business Daily

  30. Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)

    Benzinga

  31. These Three Prominent Stocks Have Doubled in 2012

    Benzinga

  32. Vivus Soars On Qsymia Anti-Obesity Drug Prescriptions

    Investors Business Daily

  33. Yahoo, LinkedIn, Lennar: Big Profit Estimate Beaters

    Investors Business Daily

  34. Amgen, Gilead, Regeneron Among 7 Best Biotech Stocks

    Investors Business Daily

  35. Regeneron's EYLEA Submitted for EU Marketing Authorization for ...

    Benzinga

  36. Regeneron, Kors: Top 5 Big Cap Leaders By Sales Gains

    Investors Business Daily

  37. Comcast, Regeneron, Biogen Idec Spur New Products

    Investors Business Daily

  38. Stock Averages Back Off In Mixed Volume

    Investors Business Daily

  39. Stocks Worsen In Late Trade; Sturm Ruger Pares Losses

    Investors Business Daily

  40. Celgene, Regeneron Pharmaceutical Lead Biomed Group

    Investors Business Daily

  41. Alkermes' Acquisition Proves To Be Game-Changer

    Investors Business Daily

  42. Regeneron Pharmaceuticals, Inc. (REGN) Chairman of the Board P Roy ...

    GuruFocus

  43. Stocks Rise, Shaking Off Sour Note From House Speaker

    Investors Business Daily

  44. Stocks Stay Positive As Regeneron Leaps To Fresh High

    Investors Business Daily

  45. Regeneron Pharmaceuticals, Inc. (REGN) Chairman of the Board P Roy ...

    GuruFocus

  46. Regeneron's EYLEA Injection Approved for Treatment of Wet ...

    Benzinga

  47. Regeneron Pharmaceuticals, Inc. (REGN) Chairman of the Board P Roy ...

    GuruFocus

  48. Stocks Open Lower In Soft Trade; Hewlett-Packard Crumbles

    Investors Business Daily

  49. Stocks Rise As Fiscal Cliff Talks Raise Hopes

    Investors Business Daily

  50. Stocks Down Modestly; Regeneron Jumps, But Hibbett Slides

    Investors Business Daily

  51. From Earlier: CHMP Recommends Granting of Marketing Authorization ...

    Benzinga

  52. Regeneron Pharmaceuticals, Inc. (REGN) SVP Finance and Admin CFO ...

    GuruFocus

  53. WuXi, Regeneron In Buying Range Despite Market's Woes

    Investors Business Daily

  54. Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)

    Benzinga

  55. Big Pharma on the Defensive: Sanofi Caves on Oncology-Drug, ...

    YCharts

  56. Stocks Stay In Deep Red; Whole Foods Reports After Close

    Investors Business Daily

  57. Sanofi, Regeneron Begin Enrollment in CV Outcomes Trial with PCSK9 ...

    Benzinga

  58. Edward Owens' Vanguard Health Care Fund Does More Shedding Than ...

    GuruFocus

  59. Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)

    Benzinga

  60. Alexion EPS Tops, Shares Fall

    Investors Business Daily

  61. Rating Breakdown: Best & Worst ETFs & Mutual Funds by Sector

    Benzinga

  62. Regeneron Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus

  63. IBD 50: Alexion Earnings Beat Estimates; Stock Up

    Investors Business Daily

  64. Regeneron Profit Would Be Third Straight Quarter

    Investors Business Daily

  65. Alexion Earnings Expected To Grow, But Stock Slides

    Investors Business Daily

  66. Stocks Gain But Align, Mellanox Slide After Hours

    Investors Business Daily

  67. Sanofi's New Cancer Drug Rebuffed by Sloan-Kettering Over Cost; ...

    YCharts

  68. Medical Leaders Hang Tough; Alexion Tests Buy Point

    Investors Business Daily

  69. Nationstar, Lennar Lead EPS Outlooks in Top 20 Groups

    Investors Business Daily

  70. Stocks Extend Gains; S&P 500 Rises For Fourth Straight Session

    Investors Business Daily

  71. Stocks Turn Mixed As Techs Weigh; Regeneron Pharma Gains

    Investors Business Daily

  72. Regeneron's EYLEA Injection Approved for Treatment of Wet ...

    Benzinga

  73. SolarWinds, Three Other Stocks Testing 10-Week Lines

    Investors Business Daily

  74. Short Interest in Biotech Firms Resumes (BIIB, GILD, ILMN, REGN)

    Benzinga

  75. Biogen, Cubist and Alexion Not The Only Biomed Leaders

    Investors Business Daily

  76. UPDATE: Goldman Sachs Raises PT to $170 on Regeneron ...

    Benzinga

  77. Regeneron Announces FDA Approval of EYLEA

    Benzinga

  78. Regeneron Pharma Says Eylea Injection Recommend for Approval by CHMP

    Benzinga

  79. Amgen Bounces Back On Strong 2012 Performance

    Investors Business Daily

  80. Regeneron Pulls Back Into Buy Area

    Investors Business Daily

  81. 52-Week High Companies: ZMH, CVX, V, REGN, DFS

    GuruFocus

  82. Regeneron Pharmaceuticals: Continuous loss making company delivers ...

    GuruFocus

  83. Stocks Open Modestly Lower; HMS Holdings Sells Off

    Investors Business Daily

  84. Regeneron Trying To Break Out, Near New High

    Investors Business Daily

  85. Stocks Close Lower But Volume Eases

    Investors Business Daily

  86. Stocks Crawl Off Lows; S&P 500 Tests 1400

    Investors Business Daily

  87. Regeneron Pharmaceuticals Spokesperson Declines Comment on Earlier ...

    Benzinga

  88. Lennar, Other Homebuilders Crush Profit Estimates

    Investors Business Daily

  89. 52-Week High Companies: BAM, REGN, TRV, WFC

    GuruFocus

  90. Health Care Stocks Continue To Lead Market

    Investors Business Daily

  91. Short Sellers Shy Away from Biotech Firms

    Benzinga

  92. Biotechs: Basing, With Possible Leaders On Deck

    Investors Business Daily

  93. Top-Performing Funds Latch On To Biotech And Discount Retail Stocks

    Investors Business Daily

  94. Regeneron Forms Cup-Type Base, Possible 145.14 Entry

    Investors Business Daily

  95. Biotechs In Motion As New Drug Pipeline Brims

    Investors Business Daily

  96. Health Care Sector Wrap

    FOXBusiness

  97. Regeneron Pharma

    Investors Business Daily

  98. Social Media Outlook for Wednesday July 25 (RVBD, REGN, IGT, NFLX)

    Benzinga

  99. Regeneron Plunges From Open After Earnings; Stock Still Higher

    Benzinga

  100. Symantec, Altera Among Stocks Up on High Volume Wednesday

    FOXBusiness
People viewing REGN also viewed: , , , , , ,
Marketplace
Trading Center